Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
AMGEN | 10 | 27 | +0,27 % | ||
AMARIN | 9 | 5 | +1,44 % | ||
REVOLUTION MEDICINES | 9 | 5 | -0,58 % | ||
NUVALENT | 8 | - | 0,00 % | ||
ROYALTY PHARMA | 7 | - | -0,61 % | ||
CUREVAC | 4 | 9 | -1,25 % | ||
INDIVIOR | 4 | 4 | -0,83 % | ||
SAREPTA THERAPEUTICS | 4 | 1 | +1,50 % | ||
FORTREA | 4 | 1 | -1,31 % | ||
COMPASS PATHWAYS | 3 | 11 | +0,91 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10:46 | FDA approves Sanofi and Regeneron's Dupixent for bullous pemphigoid | 5 | Pharmaceutical Technology | ||
10:43 | 10X Genomics Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | Felix Haupt | |||
10:06 | Alvotech: Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair (omalizumab) | 38 | GlobeNewswire (Europe) | REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines... ► Artikel lesen | |
08:34 | Indivior beruft Tony Kingsley in den Vorstand | 2 | Investing.com Deutsch | ||
08:18 | Indivior appoints Tony Kingsley to board of directors | 1 | Investing.com | ||
08:00 | Sanofi's Riliprubart Secures U.S. Orphan Drug Status For Solid Organ Transplant Rejection | 143 | AFX News | PARIS (dpa-AFX) - The U.S. Food and Drug Administration has granted orphan drug designation to riliprubart for the investigational treatment of antibody-mediated rejection (AMR) in solid organ... ► Artikel lesen | |
08:00 | MaxCyte, Inc. - Last Day of Dealings on AIM | - | RNS | ||
08:00 | Indivior PLC - Indivior Appoints Tony Kingsley to the Board | - | RNS | ||
07:10 | Sanofi Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation | 206 | GlobeNewswire (Europe) | Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment... ► Artikel lesen | |
05:46 | BioNTech schluckt CureVac! Evotec und Vidac als nächstes? Kurstreiber Übernahme und Kaufempfehlung | 969 | ESG-Aktien.de | Steht bei Vidac Pharma eine neue Kursexplosion bevor? Im vergangenen Herbst ging es um rund 200 % nach oben. Gestern gab es eine Kaufempfehlung. Die Analysten sehen bei der Biotech-Perle Vervielfachungspotenzial.... ► Artikel lesen | |
04:50 | Stock Alert: PTC Inds, Mastek, Aurobindo Pharma, JB Chemicals, Hindalco Inds | 2 | capitalmarket.com | ||
04:29 | Amarin Grants Recordati Exclusive Rights To Commercialize VAZKEPA Across 59 European Countries | 6 | RTTNews | ||
03:59 | FDA Grants Priority Review To Syndax's Revuforj For R/R MNPM1 Acute Myeloid Leukemia Treatment | - | RTTNews | ||
02:26 | Tempus AI, Inc. (TEM): A Bull Case Theory | 12 | Insider Monkey | ||
Di | Ideaya Biosciences-Aktionäre wählen Direktoren und genehmigen Wirtschaftsprüfer bei Jahresversammlung | 1 | Investing.com Deutsch | ||
Di | IDEAYA Biosciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
Di | Clear Street stuft ArriVent BioPharma-Aktie mit Kaufempfehlung ein | 2 | Investing.com Deutsch | ||
Di | Sarepta's Elevidys under FDA probe after two patient deaths | 9 | Investing.com | ||
Di | Clear Street initiates ArriVent BioPharma stock with Buy rating | 3 | Investing.com | ||
Di | FDA untersucht Sarepta's Elevidys nach zwei Todesfällen | 15 | Investing.com Deutsch |